Company intelligence / Profile preview

OncoMAGNETX

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

OncoMAGNETX is an early-stage biotechnology company focused on developing innovative cancer treatments using magnetic nanoparticle technology. The company's platform leverages specialized magnetic particles designed to deliver therapeutic payloads directly to tumor sites or to induce localized hyperthermia to destroy cancer cells. By utilizing external magnetic fields to guide and activate these nanoparticles, OncoMAGNETX aims to increase the precision of oncology treatments while minimizing systemic side effects. Their current research is primarily in the pre-clinical phase, targeting various solid tumor indications.

Therapeutic areas: Oncology
Modalities: NanoparticleDeviceDrug delivery system
Industry: Biotech

Beyond the preview

Go deeper on OncoMAGNETX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OncoMAGNETX.

Explore the full profile